The Carnot Calym Institute represents a unique ecosystem bringing together the best French experts and cooperative groups to advance R&D on lymphoid neoplasms. From the discovery of biomarkers to phase III clinical trials for registration and beyond, the expertise of the Carnot Calym Institute covers the entire value chain.
Internationally recognized cooperative groups of clinical research professionals, responsible for many major advances in the treatment of lymphoma (HL, NHL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and related cancers.
An independent network of expert professionals and an international leader in clinical research on lymphoma and chronic lymphocytic leukemia.
Expert researchers in hematology, immunology and oncology, distributed across the largest research centers and hospitals in France
A non-profit association and operational structure for the coordination and animation of the Carnot Calym Institute. Calym’s vision is to become a key center for academic investment in lymphoid neoplasms.
Unrivaled expertise, collective strength, a common ambition :
accelerate discoveries and transform research into concrete solutions for patients.
of annual contractual revenues
A strong indicator of the confidence of our industrial and academic partners, proof of our growing impact on therapeutic research and innovation
Ongoing R&D projects
Our expertise covers the entire continuum of biomedical research, from early stages in the laboratory to advanced phases of clinical trials.
Our growth over 13 years
Annual investment budget
With recognized expertise in managing industrial, European and international projects, the Carnot Calym Institute is positioning itself as a leader in transforming research on lymphoid hematological disorders into concrete progess for patients.
The Carnot label is awarded by the Ministry of Higher Education, Research and Innovation to the most successful research structures, capable of:
• Embodying recognized scientific excellence
• Collaborating effectively with industry, from start-ups to large multinationals
• Generating a tangible impact on innovation and economic competitiveness
Obtaining this label is the guarantee of the highest standard:
A level of expertise, professionalism and responsiveness that guarantees the success of collaborative R&D projects.
